Zactima - Tyrosine Kinase Inhibitor for Treatment of Lung Cancer

Print

Tyrosine kinase inhibitors are now used to treat several cancers including NSCLC.
 
«Back | Next»

Return to Profile




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development